Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

PCSA holding history

Processa Pharmaceuticals, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCSA overviewAll 13F holders of PCSAFull Q4 2025 holdings

Shares (Q4 2025)
23,586
Value
$67.9K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of PCSA by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202523,586$67.9K<0.1%−264,626−91.8%ReducedHolders
Q3 2025288,212$55.3K<0.1%+263,779+1,079.6%AddedHolders
Q2 202524,433$5.01K<0.1%00.0%UnchangedHolders
Q1 202524,433$9.04K<0.1%00.0%UnchangedHolders
Q4 202424,433$21.7K<0.1%00.0%UnchangedHolders
Q3 202424,433$33.5K<0.1%00.0%UnchangedHolders
Q2 202424,433$54.7K<0.1%00.0%UnchangedHolders
Q1 202424,433$57.8K<0.1%−210,220−89.6%ReducedHolders
Q4 2023234,653$78.5K<0.1%−109,772−31.9%ReducedHolders
Q3 2023344,425$86.2K<0.1%−17,254−4.8%ReducedHolders
Q2 2023361,679$179.9K<0.1%00.0%UnchangedHolders
Q1 2023361,679$180.9K<0.1%−12,148−3.2%ReducedHolders
Q4 2022373,827$411.2K<0.1%+1290.0%AddedHolders
Q3 2022373,698$845.0K<0.1%+1000.0%AddedHolders
Q2 2022373,598$1.05M<0.1%00.0%UnchangedHolders
Q1 2022373,598$1.13M<0.1%00.0%UnchangedHolders
Q4 2021373,598$1.83M<0.1%−293−0.1%ReducedHolders
Q3 2021373,891$3.20M<0.1%+720+0.2%AddedHolders
Q2 2021373,171$3.06M<0.1%+215,532+136.7%AddedHolders
Q1 2021157,639$1.72M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.